Eduardo Hernandez
Hematology & Oncology · San Juan, PRNPI 1780049650
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,560 of the $7,045 with a category attached, or 78.9%. 33 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 27.6% of the total. Reporting peaked in 2023 at $2,673 and has fallen 99.3% since, to $19 in 2025. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 223 payments — averaging $31.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$2K
- PBG Puerto Rico LLC$736
- Johnson & Johnson$711
- Amgen$614
- AbbVie$547
- AstraZeneca$449
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$1,20017%
- Food & beverage$5,56079%
- Education$2854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 21 | $1,947 |
| PBG Puerto Rico LLC | 35 | $736 |
| Johnson & Johnson(2 entities) | 24 | $711 |
| Amgen | 17 | $614 |
| AbbVie | 26 | $547 |
| AstraZeneca | 24 | $449 |
| Incyte Corporation | 4 | $332 |
| Eli Lilly Export S.A. Puerto Rico Branch | 8 | $183 |
| Merck | 10 | $180 |
| Novartis | 8 | $171 |
| Sanofi | 7 | $154 |
| Rigel Pharmaceuticals, Inc. | 1 | $125 |
| Abbott | 2 | $117 |
| Sanofi-aventis U.S. LLC | 2 | $76 |
| Seagen Inc. | 3 | $68 |
| Pfizer | 3 | $66 |
| GSK | 3 | $65 |
| Puma Biotechnology, Inc. | 3 | $63 |
| Bayer Puerto Rico Inc. | 3 | $51 |
| Astellas Pharma US Inc | 3 | $51 |
| Genentech USA, Inc. | 2 | $49 |
| Taiho Oncology, Inc. | 2 | $38 |
| Bayer | 2 | $36 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $29 |
| Tolmar, Inc. | 1 | $25 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $23 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Sobi, Inc | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Tempus AI, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,045 in reported general payments places this provider in the 40th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 11 | $155,403 |
| EliquisApixaban | 40 | $25,138 |
| RetacritEpoetin Alfa-Epbx | 21 | $11,098 |
| Sucralfate | 25 | $3,820 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $1,090 |
| Dexamethasone | 32 | $764 |
| Bicalutamide | 22 | $753 |
| Hydroxyurea | 18 | $405 |
| Ondansetron Hcl | 22 | $334 |
| LoperamideLoperamide Hcl | 11 | $267 |
| Anastrozole | 17 | $205 |
| Prednisone | 36 | $179 |
| Montelukast Sodium | 15 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi | $51 | $155,40311 claims |
| PfizerEliquis, Retacrit | $66 | $36,23661 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in San Juan
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Edgardo Santiago-GuzmanSan Juan$79K
- Adelba Torres-LopezSan Juan$73K
- Karla Feliciano SalvaSan Juan$44K
- Luis Delgado MateuSan Juan$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.